CD44 and breast carcinoma: In the tumor cells from breast cancer survivors undergoing chemotherapy, the proportion of BCSCs with CD44+CD24− phenotype after chemotherapy was significantly increased compared with that before chemotherapy, and the ability of BCCs to form microspheres was also improved.